{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:27:30Z","timestamp":1787686050729,"version":"build-2784847793"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1991,7,1]],"date-time":"1991-07-01T00:00:00Z","timestamp":678326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[1991,7]]},"DOI":"10.1007\/bf02072625","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T08:35:21Z","timestamp":1124008521000},"page":"642-646","source":"Crossref","is-referenced-by-count":23,"title":["Salicylate treatment in Kawasaki disease: high dose or low dose?"],"prefix":"10.1007","volume":"150","author":[{"given":"T.","family":"Akagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02072625_CR1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1253\/jcj.43.633","volume":"43","author":"S Amano","year":"1979","unstructured":"Amano S, Hayama F, Tasaka K, Kubagawa H, Hamashima Y (1979) Pathology of Kawasaki disease. Pathology and morphogenesis of the vascular changes. Jpn Circ J 43:633\u2013634","journal-title":"Jpn Circ J"},{"key":"BF02072625_CR2","first-page":"162","volume":"6","author":"M Awakura","year":"1986","unstructured":"Awakura M, Asai T (1986) The hepatic damage on Kawasaki disease and therapy. Prog Med (In Japanese) 6:162\u2013168","journal-title":"Prog Med"},{"key":"BF02072625_CR3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1172\/JCI108941","volume":"61","author":"JW Burch","year":"1978","unstructured":"Burch JW, Stanford N, Majerus PW (1978) Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 61:314\u2013319","journal-title":"J Clin Invest"},{"key":"BF02072625_CR4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(84)80114-6","volume":"105","author":"JC Burns","year":"1984","unstructured":"Burns JC, Glode MP, Clarke SH, Wiggins J, Hathaway WE (1984) Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients a high risk for development of coronary artery aneurysms. J Pediatr 105:206\u2013211","journal-title":"J Pediatr"},{"key":"BF02072625_CR5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0002-9149(86)90609-0","volume":"57","author":"T Fujiwara","year":"1986","unstructured":"Fujiwara T, Fujiwara H, Ueda T, Nishioka K, Hamashima Y (1986) Comparison of macroscopic, ppstmortem, angiographic and two-dimensional echocardiographic findings of coronary aneurysms in children with Kawasaki disease. Am J Cardiol 57:761\u2013764","journal-title":"Am J Cardiol"},{"key":"BF02072625_CR6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0002-9149(88)91177-0","volume":"61","author":"DR Fulton","year":"1988","unstructured":"Fulton DR, Meissner HC, Peterson MB (1988) Effects of current therapy of Kawasaki disease on eicosanoid metabolism. Am J Cardiol 61:1323\u20131327","journal-title":"Am J Cardiol"},{"key":"BF02072625_CR7","first-page":"2214","volume":"90","author":"Y Hamasaki","year":"1986","unstructured":"Hamasaki Y, Ichimura T, Hattori T, Tasaki H, Miyazaki S (1986) Aspirin therapy for Kawasaki disease (MCLS): action for arachidonic acid metabolism in platelets and vascular endothelium. Acta Paediatr Jpn (In Japanese) 90:2214\u20132222","journal-title":"Acta Paediatr Jpn (In Japanese)"},{"key":"BF02072625_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1442-200X.1988.tb02498.x","volume":"30","author":"Y Hamasaki","year":"1988","unstructured":"Hamasaki Y, Ichimura T, Tasaki H, Miyazaki S (1988) Studies on the effect of long-term use of low dose aspirin in Kawasaki disease. Acta Paediatr Jpn Overseas ed 30:63\u201367","journal-title":"Acta Paediatr Jpn Overseas ed"},{"key":"BF02072625_CR9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(81)91733-5","volume":"I","author":"SP Hanley","year":"1981","unstructured":"Hanley SP, Bevan J, Cockbill SR, Heptinstall S (1981) Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet I: 969\u2013971","journal-title":"Lancet"},{"key":"BF02072625_CR10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0031-3955(16)36113-2","volume":"33","author":"RV Hicks","year":"1986","unstructured":"Hicks RV, Melish ME (1986) Kawasaki syndrome. Pediatr Clin North Am 33:1151\u20131175","journal-title":"Pediatr Clin North Am"},{"key":"BF02072625_CR11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-3476(83)80300-X","volume":"102","author":"T Hidaka","year":"1983","unstructured":"Hidaka T, Nakano M, Ueta T, Komatsu Y, Yamamoto M (1983) Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki disease. J Pediatr 102:94\u201396","journal-title":"J Pediatr"},{"key":"BF02072625_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00007691-197901000-00013","volume":"1","author":"JC Jacobs","year":"1979","unstructured":"Jacobs JC (1979) Salicylate treatment of epidemic Kawasaki disease in New York City. Ther Drug Monit 1:123\u2013130","journal-title":"Ther Drug Monit"},{"key":"BF02072625_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1542\/peds.63.2.175","volume":"63","author":"H Kato","year":"1979","unstructured":"Kato H, Koike S, Yokoyama T (1979) Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 63:175\u2013179","journal-title":"Pediatrics"},{"key":"BF02072625_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1542\/pir.9-7-209","volume":"9","author":"H Kato","year":"1988","unstructured":"Kato H, Inoue O, Akagi T (1988) Kawasaki disease: cardiac problems and management. Pediatr Rev 9:209\u2013217","journal-title":"Pediatr Rev"},{"key":"BF02072625_CR15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3476(84)80097-9","volume":"105","author":"G Koren","year":"1984","unstructured":"Koren G, MacLeod SM (1984) Difficulty in achieving therapeutic serum concentrations of salicylates in Kawasaki disease. J Pediatr 105:991\u2013995","journal-title":"J Pediatr"},{"key":"BF02072625_CR16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.1985.03360060069027","volume":"254","author":"G Koren","year":"1985","unstructured":"Koren G, Rose V, Lavi S, Rowe R (1985) Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. JAMA 254:767\u2013769","journal-title":"JAMA"},{"key":"BF02072625_CR17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0022-3476(88)80194-X","volume":"112","author":"G Koren","year":"1988","unstructured":"Koren G, Schaffer F, Silverman E, Walker S, Duffy C, Stein L, Suria D, Schue S, Thiessen JJ, Gelfand E, Laxer R (1988) Determination of low serum concentrations of salicylates in patients with Kawasaki disease. J Pediatr 112:663\u2013667","journal-title":"J Pediatr"},{"key":"BF02072625_CR18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","volume":"315","author":"JW Newburger","year":"1986","unstructured":"Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, Shulman ST, Wiggins JW, Hicks RV, Fulton DR, Lewis AB, Leung DYM, Colton T, Rosen FS, Melish ME (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341\u2013347","journal-title":"N Engl J Med"},{"key":"BF02072625_CR19","volume-title":"Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease","author":"Research Committee on Kawasaki disease","year":"1984","unstructured":"Research Committee on Kawasaki disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, Japan"},{"key":"BF02072625_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3476(82)80639-2","volume":"100","author":"Y Sasaguri","year":"1982","unstructured":"Sasaguri Y, Kato H (1982) Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr 100:225\u2013231","journal-title":"J Pediatr"},{"key":"BF02072625_CR21","first-page":"952","volume":"37","author":"K Sasai","year":"1988","unstructured":"Sasai K (1988) Plasma PGE2, TxB2, 6-keto PGF1\u03b1 levels in patients with Kawasaki disease. Allergy (In Japanese) 37:952\u2013958","journal-title":"Allergy"},{"key":"BF02072625_CR22","first-page":"565","volume-title":"Kawasaki disease","author":"K Sasai","year":"1987","unstructured":"Sasai K, Furukawa S, Yabuta K (1987) The metabolism of the archidonic cascade in patients with Kawasaki disease. In: Shulman ST (ed) Kawasaki disease. Alan R. Liss, New York, pp 565\u2013566"},{"key":"BF02072625_CR23","first-page":"493","volume-title":"Kawasaki disease","author":"M Takahashi","year":"1987","unstructured":"Takahashi M, Kato H (1987) Can consensus be reached in cardiac management of Kawasaki syndrome?: review of a survey among Japanese and U.S. pediatric cardiologists. In: Shulman ST (ed) Kawasaki disease. Alan R. Liss, New York, pp 493\u2013508"},{"key":"BF02072625_CR24","first-page":"1844","volume":"90","author":"The Kawasaki disease research committee","year":"1986","unstructured":"The Kawasaki disease research committee (1986) A randomized controlled study of three different therapies for patients having Kawasaki disease. Act Paediatr Jpn (in Japanese) 90: 1844\u20131849","journal-title":"Act Paediatr Jpn"},{"key":"BF02072625_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2739\/kurumemedj.27.57","volume":"27","author":"T Yokoyama","year":"1980","unstructured":"Yokoyama T, Kato H, Ichinose E (1980) Aspirin treatment and platelet function in Kawasaki disease. Kurume Med J 27:57\u201361","journal-title":"Kurume Med J"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02072625.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02072625\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02072625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T05:48:06Z","timestamp":1683179286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02072625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,7]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1991,7]]}},"alternative-id":["BF02072625"],"URL":"https:\/\/doi.org\/10.1007\/bf02072625","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,7]]}}}